UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
500.13
+10.88 (2.22%)
At close: Dec 20, 2024, 4:00 PM
501.50
+1.37 (0.27%)
After-hours: Dec 20, 2024, 7:24 PM EST
UnitedHealth Group Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for UnitedHealth Group stock have an average target of 617.63, with a low estimate of 460 and a high estimate of 675. The average target predicts an increase of 23.49% from the current stock price of 500.13.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for UNH stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 10 | 10 | 10 | 11 | 11 | 11 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 19 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $610 → $640 | Buy | Maintains | $610 → $640 | +27.97% | Dec 6, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $605 → $675 | Buy | Maintains | $605 → $675 | +34.96% | Dec 5, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $595 → $625 | Strong Buy | Maintains | $595 → $625 | +24.97% | Dec 3, 2024 |
| Barclays | Barclays | Buy Maintains $603 → $655 | Buy | Maintains | $603 → $655 | +30.97% | Nov 27, 2024 |
| Barclays | Barclays | Buy Maintains $604 → $603 | Buy | Maintains | $604 → $603 | +20.57% | Oct 22, 2024 |
Financial Forecast
Revenue This Year
404.75B
Revenue Next Year
435.67B
from 404.75B
Increased by 7.64%
EPS This Year
27.89
from 23.86
Increased by 16.90%
EPS Next Year
30.22
from 27.89
Increased by 8.33%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 423.8B | 466.9B | 510.0B | |||
| Avg | 404.8B | 435.7B | 468.9B | |||
| Low | 389.7B | 413.6B | 438.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 15.4% | 17.1% | |||
| Avg | - | 7.6% | 7.6% | |||
| Low | - | 2.2% | 0.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 29.14 | 32.50 | 36.78 | |||
| Avg | 27.89 | 30.22 | 33.99 | |||
| Low | 26.76 | 28.67 | 31.76 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 22.1% | 16.5% | 21.7% | |||
| Avg | 16.9% | 8.3% | 12.5% | |||
| Low | 12.2% | 2.8% | 5.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.